1. Home
  2. KLTOW vs MCHPP Comparison

KLTOW vs MCHPP Comparison

Compare KLTOW & MCHPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • MCHPP
  • Stock Information
  • Founded
  • KLTOW N/A
  • MCHPP N/A
  • Country
  • KLTOW United States
  • MCHPP United States
  • Employees
  • KLTOW 3
  • MCHPP 19400
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • MCHPP Semiconductors
  • Sector
  • KLTOW Health Care
  • MCHPP Technology
  • Exchange
  • KLTOW Nasdaq
  • MCHPP Nasdaq
  • Market Cap
  • KLTOW N/A
  • MCHPP N/A
  • IPO Year
  • KLTOW 2022
  • MCHPP N/A
  • Fundamental
  • Price
  • KLTOW $0.17
  • MCHPP $55.98
  • Analyst Decision
  • KLTOW
  • MCHPP
  • Analyst Count
  • KLTOW 0
  • MCHPP 0
  • Target Price
  • KLTOW N/A
  • MCHPP N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • MCHPP N/A
  • Earning Date
  • KLTOW N/A
  • MCHPP N/A
  • Dividend Yield
  • KLTOW N/A
  • MCHPP N/A
  • EPS Growth
  • KLTOW N/A
  • MCHPP N/A
  • EPS
  • KLTOW N/A
  • MCHPP N/A
  • Revenue
  • KLTOW N/A
  • MCHPP N/A
  • Revenue This Year
  • KLTOW N/A
  • MCHPP N/A
  • Revenue Next Year
  • KLTOW N/A
  • MCHPP N/A
  • P/E Ratio
  • KLTOW N/A
  • MCHPP N/A
  • Revenue Growth
  • KLTOW N/A
  • MCHPP N/A
  • 52 Week Low
  • KLTOW N/A
  • MCHPP N/A
  • 52 Week High
  • KLTOW N/A
  • MCHPP N/A
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW 50.51
  • MCHPP N/A
  • Support Level
  • KLTOW $0.15
  • MCHPP N/A
  • Resistance Level
  • KLTOW $0.17
  • MCHPP N/A
  • Average True Range (ATR)
  • KLTOW 0.02
  • MCHPP 0.00
  • MACD
  • KLTOW -0.00
  • MCHPP 0.00
  • Stochastic Oscillator
  • KLTOW 42.70
  • MCHPP 0.00

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About MCHPP Microchip Technology Incorporated

Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

Share on Social Networks: